Previous close | 20.59 |
Open | 20.55 |
Bid | 20.59 x 400 |
Ask | 20.66 x 200 |
Day's range | 20.26 - 21.25 |
52-week range | 7.41 - 24.17 |
Volume | |
Avg. volume | 920,808 |
Market cap | 1.572B |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore the pivotal updates from Kura Oncology's Q1 2024 earnings call, including financial shifts and significant clinical milestones.
Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript February 27, 2024 Kura Oncology, Inc. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.56. Kura Oncology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
Q4 2023 Kura Oncology Inc Earnings Call